We are pleased to roll out the next issue of EUnetHTA Magazine. As we are now experimenting with a web-based format, we hope to provide a more interactive experience for readers, whether that's on desktop, tablet, or mobile device. In this
EUnetHTA is pleased to announced that the document on "Patient Input in Relative Effectiveness Assessments" is now available. The document describes the process regarding direct patient input in REAs within JA3. The document is primarily intended for those who design and
This year's HTAi Annual Meeting will take place from 15 to 19 June in Cologne, Germany. The meeting brings together HTA experts from across the world for five days of discussions, panels, presentations and more. This year's theme "HTA beyond 2020: Ready for the New Decade" focusses on
PTJA04 – “Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy” is now available
This is the assessment of the relative effectiveness of ‘Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed
Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spaces for Prostate Cancer Radiotherapy
EUnetHTA recently started a new Collaborative Assessment on a Medical Device for rectum spacers for prostate cancer radiotherapy. To find out about participation, please read more here. Input submissions will be received through EOB, Friday 5th July.